Synthesis and Pharmacokinetics of Nanosized NH2‑UiO‑66 (Zr) Metal-Organic Frameworks

Синтез и фармакокинетика наноразмерных NH2‑UiO‑66 (Zr) металлоорганических каркасов
A. B. Mirkasymov, V. I. Rodionov, D. A. Pokhorukov, O. Yu. Griaznova, N. K. Ivshina, I. V. Lunyov, I. V. Zelepukin, S. M. Deyev
2025-12-01

NH2-UiO-66 (Zr)doxorubicin loadingnanosized metal-organic frameworkspharmacokinetics / prolonged circulationpolyethylene glycol (PEG) surface functionalization
Abstract The application of porous nanomaterials in drug delivery offers a promising strategy to mitigate the adverse side effects of chemotherapy. In this study, we report the synthesis of nanosized NH 2 -UiO-66 (Zr) metal-organic frameworks as carriers of doxorubicin. The nanoparticles exhibited high crystallinity with an average size of 44 nm. Surface functionalization with polyethylene glycol (PEG) markedly enhanced their colloidal stability under physiological conditions. Coated NH 2 -UiO-66 (Zr)@PEG particles demonstrated prolonged circulation in the bloodstream and a significant reduction of nonspecific accumulation in organs with high vascularization. Importantly, these particles retained their capacity for doxorubicin loading, highlighting their potential for drug delivery.
1
NH2-UiO-66 (Zr)@PEG particles exhibited prolonged bloodstream circulation and reduced nonspecific accumulation in highly vascularized organs.
2
Nanosized NH2-UiO-66 (Zr) metal-organic framework nanoparticles were synthesized as doxorubicin carriers.
3
PEG surface functionalization markedly enhanced colloidal stability under physiological conditions.
4
PEG-coated particles retained their capacity to load doxorubicin, supporting their potential for drug delivery.
5
The synthesized nanoparticles showed high crystallinity and an average size of 44 nm.

Nanosized NH2-UiO-66 (Zr) metal-organic framework nanoparticles (including PEG-coated NH2-UiO-66 (Zr)@PEG) used as doxorubicin carriers

Synthesis, surface PEG functionalization, colloidal stability, doxorubicin loading capacity, and in vivo pharmacokinetics (circulation time and organ biodistribution reduction of nonspecific accumulation) of the nanoparticles

Publication Details
Publication Date
2025-12-01
Journal
Publisher
ISSN
Cited by
2
Access Type
Author Information
Authors
A. B. Mirkasymov
V. I. Rodionov
D. A. Pokhorukov
O. Yu. Griaznova
N. K. Ivshina
I. V. Lunyov
I. V. Zelepukin
S. M. Deyev
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%